Lifestyle risk factors for invasive pneumococcal disease: A systematic review

BMJ Open

Volumn 4, Issue 6, 2014, Pages

  Cruickshank, Helen C ^a   Jefferies, Johanna M ^a   Clarke, Stuart C ^a,b,c  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b University Hospital Southampton NHS Foundation Trust   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGE; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOLISM; ASTHMA; BODY MASS; CHRONIC KIDNEY FAILURE; CHRONIC LUNG DISEASE; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; EDUCATIONAL STATUS; ETHNICITY; GENDER; HEART DISEASE; HUMAN; INCOME; LIFESTYLE; MALIGNANT NEOPLASTIC DISEASE; PASSIVE SMOKING; PNEUMOCOCCAL INFECTION; REVIEW; RISK FACTOR; SMOKING; STREPTOCOCCUS PNEUMONIA; SYSTEMATIC REVIEW; UNEMPLOYMENT; ADVERSE EFFECTS; DRINKING BEHAVIOR; PNEUMOCOCCAL INFECTIONS;

ALCOHOL DRINKING; HUMANS; LIFE STYLE; PNEUMOCOCCAL INFECTIONS; RISK FACTORS; SMOKING;

EID: 84903123740     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-005224     Document Type: Review

References (35)

1. Edmond K, Clark A, Korczak VS, et al. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis 2010;10:317-28.
2. Gladstone RA, Jefferies JM, Faust SN, et al. Continued control of pneumococcal disease in the UK - the impact of vaccination. J Med Microbiol 2011;60:1-8.
3. Joint Committee on Vaccination and Immunisation. JCVI statement on the wider use of pneumococcal conjugate vaccines in the UK. Department of Health, 2013.
4. World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2013 global summary. [online].
5. Miller E, Andrews NJ, Waight PA, et al. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet 2011;11:760-8.
6. Van Hoek AJ, Andrews N, Waight PA, et al. The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England. J Infect 2012;65:17-24.
7. Muhammad RD, Oza-Frank R, Zell E, et al. Epidemiology of invasive pneumococcal disease among high risk adults since the introduction of pneumococcal conjugate vaccine for children. Clin Infect Dis 2013;56:e59-67.
8. Department of Health. Immunisation against infectious disease (The Green Book) Chapter 25: Pneumococcal - updated 19 April 2013. [on-line].
9. Schoenmakers MCJ, Hament JM, Fleer A, et al. Risk factors for invasive pneumococcal disease. Rev Med Microbiol 2002;13:29-36. (Pubitemid 34188752)
10. Feldman C, Anderson R. New insights into pneumococcal disease. Respirology 2009;14:167-79.
11. Lynch IJP, Zhanel GG. Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention. Semin Respir Crit Care Med 2009;30:189-209.
12. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535.
13. National Institute for Health and Clinical Excellence. Methods for the development of NICE public health guidance (third edition), [online].
14. Jover F, Cuadrado J-M, Andreu L, et al. A comparative study of bacteremic and non-bacteremic pneumococcal pneumonia. Eur J Intern Med 2008;19:15-21.
15. Musher DM, Alexandraki I, Graviss EA, et al. Bacteremic and nonbacteremic pneumococcal pneumonia. A prospective study. Medicine (Baltimore) 2000;79:210-21. (Pubitemid 30618052)
16. Kyaw MH, Rose CE Jr, Fry AM, et al. The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults. J Infect Dis 2005;192:377-86. (Pubitemid 41023115)
17. Nuorti JP, Butler JC, Farley MM, et al. Cigarette smoking and invasive pneumococcal disease. N Engl J Med 2000;342:681-9. (Pubitemid 30131420)
18. Watt JP, O 'Brien KL, Benin AL, et al. Risk factors for invasive pneumococcal disease among Navajo adults. Am J Epidemiol 2007;166:1080-7.
19. Pastor P, Medley F, Murphy TV. Invasive pneumococcal disease in Dallas County, Texas: results from population-based surveillance in 1995. Clin Infect Dis 1998;26:590-5. (Pubitemid 28155004)
20. Flory JH, Joffe M, Fishman NO, et al. Socioeconomic risk factors for bacteraemic pneumococcal pneumonia in adults. Epidemiol Infect 2009;137:717-26.
21. Jacups SP, Cheng A. The epidemiology of community acquired bacteremic pneumonia, due to Streptococcus pneumoniae, in the top end of the northern territory, Australia-over 22 years. Vaccine 2011;29:5386-92.
22. Lipsky BA, Boyko EJ, Inui TS, et al. Risk factors for acquiring pneumococcal infections. Arch Intern Med 1986;146:2179-85. (Pubitemid 17189092)
23. Inghammar M, Engström G, Kahlmeter G, et al. Invasive pneumococcal disease in patients with an underlying pulmonary disorder. Clin Microbiol Infect 2013;19:1148-54.
24. Huttunen R, Heikkinen T, Syrjanen J. Smoking and the outcome of infection. J Intern Med 2011;269:258-69.
25. Szabo G, Mandrekar P. A recent perspective on alcohol, immunity, and host defense. Alcohol Clin Exp Res 2009;33:220-32.
26. Centers for Disease C, Prevention, Advisory Committee on Immunization P. Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR Morb Mortal Wkly Rep 2010;59:1102-6.
27. Moberley S, Holden J, Tatham D, et al. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2013;1:CD000422.
28. Cohen AL, Harrison LH, Farley MM, et al. Prevention of invasive pneumococcal disease among HIV-infected adults in the era of childhood pneumococcal immunization. AIDS 2010;24:2253-62.
29. Health and Social Care Information Centre, Lifestyles Statistics. Statisitcs on smoking: England, 2012: HSCIC, 2012.
30. Parsons HK, Metcalf SC, Tomlin K, et al. Invasive pneumococcal disease and the potential for prevention by vaccination in the United Kingdom. J Infect 2007;54:435-8. (Pubitemid 46584427)
31. Centers for Disease Control and Prevention. 2009 Adult Vaccination Coverage, NHIS [on-line].
32. Centers for Disease Control and Prevention. Active bacterial core surveillance report, emerging infections program network, Streptococcus pneumoniae, 2010. Atlanta: CDC, 2012.
33. NNDSS Annual Report Writing Group. Australia's notifiable disease status, 2010: annual report of the national notifiable diseases surveillance system. Commun Dis Intell 2012;36:1-69.
34. Australian Government, Department of Health and Ageing. The Australian Immunisation Handbook, 10th Edition 2013.
35. European Centre for Disease Prevention and Control. Annual epidemiological report 2012. Reporting on 2010 surveillance data and 2011 epidemic intelligence data. Stockholm: ECDC, 2013.